Biological properties of valve materials using RGD and EC.

Chennian Xu1,2,3, Yang Liu2, Rui Qiao4

  • 1Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Department of Pharmacology, School of Pharmacy, The Fourth Military Medical University, Xi'an, 710032, Shaanxi, China.

PubMed
Summary

A new treatment using arginine-glycine-aspartate (RGD) peptide and epoxy chloropropane (EC) enhances biological valve materials. This RGD and EC treatment improves cell adhesion and reduces cell death, optimizing valve performance.

Related Concept Videos